Announcing Green Horizons, a Trailblazing Cannabis Cultivation and CPG Brand Campus
Green Horizons’ State-of-the-Art Cannabis Cultivation and CPG Brand Campus is on Track to Make Coachella Valley to Cannabis What Silicon Valley is to Tech
COACHELLA VALLEY, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Today Green Horizons announced plans for its massive, trailblazing Canna-Campus in Coachella Valley, which broke ground late last year and is under construction. The first-of-its-kind facility will feature scaled cannabis cultivation alongside CPG brand development, positioning the Company to become one of the largest vertically integrated brand platforms in the world. Green Horizons will also offer campus tours, education and workshops to outside visitors.
Green Horizons is launching the first 226,787 sq. ft. of its campus with options to scale to 1,000,000 sq. ft. as market conditions dictate. Phase I of the Green Horizons campus will consist of 101,787 sq. ft. of a state-of-the-art, sealed, Class “A” automated light deprivation greenhouse. Phase II adds an additional 125,000 sq. ft. that will serve as the Company’s corporate headquarters as well as its brand incubator, along with additional light deprivation greenhouse cultivation space.
Green Horizons’ mission is to fuel a portfolio of in-house brands with in-house supply to guarantee consistency and uniformity. Combining the management team’s track record of cultivation excellence with the Company’s high-tech sun powered cultivation facilities, Green Horizons aims to redefine the cultivation landscape to create a blue ocean of top shelf flower at greenhouse COGS. In leveraging its low-cost basis, Green Horizons will be able to continue scaling as commoditization exerts downward pressure on higher cost producers.
The Company will be formally announcing their much-anticipated debut brand, a crossover from the fashion world, which will launch in Q3 of 2022, to be followed by a value brand paying homage to the Coachella Valley, anticipated in summer 2023. Upon completion of the facility, the brands will be exclusively powered by proprietary genetics bred in-house by the Company, a cornerstone differentiator for all Green Horizons portfolio brands.
“The Coachella Valley is the perfect place to build a world class cultivation and CPG brand campus at this scale,” said Carlos “Los” Arias, Chief Executive Officer of Green Horizons. “Coachella has long been a stalwart agricultural community, and I am honored to now help make Coachella a global cannabis destination. Being built to last is more important than being first, and we’re just getting started.”
Green Horizons was co-founded by Arias and Michael C. Meade. Arias leads the Company’s vision to create culturally relevant brands that bring people together. Known for his high vibrational presence, Arias is an exemplar of community-minded collaboration that serves as the bedrock of the Company’s culture. Meade serves as Green Horizons’ President and largest investor. Through an unrelated entity, Meade is developing Coachella Cann Park, which is being leased to Green Horizons. Meade’s development company has secured an $18.5M construction loan from Innovative Industrial Properties to fund construction of the property.
Arias and Meade are joined by founding investor Star Branding Investment Group, LLC, which brings its global entrepreneurial prowess to Green Horizons, drawing on its success in building global brands and experience in a wide range of operational matters. Brought together, Green Horizons and its principals have the requisite capabilities in-house to scale a profitable cultivation and CPG enterprise, synchronizing facility operations expertise and global brand prowess.
Green Horizons recognizes the privilege to work within the legal cannabis space and is committed to positive social change at the local level.
Education is a pillar of the Company. With a mission to destigmatize cannabis through education and transparency, Green Horizons will open its doors to offer campus tours to outside visitors, along with workshops and educational programs for the community and those interested in learning more about the cannabis plant and the industry.
The Company is partnering with the City of Coachella in launching the Build the Valley Initiative, which will consist of two prominent initiatives: first, building infrastructure for the community; and second, advocacy for expungement and job creation for which Green Horizons will create a dedicated Coachella Valley program. In addition to their local community activism, Green Horizons is also invested in the sustainable future of the cannabis industry and is a member of an industry task force, comprised of top operators, financiers and attorneys, whose aim is to eradicate the use of plastics in the cannabis supply chain.
ABOUT GREEN HORIZONS
Green Horizons is a next gen, vertically integrated cannabis company that builds CPG brands. With world class facilities to fuel globally relevant brands, the Company’s aim is to crossover and create meaningful brands that bring people together. www.greenhorizons.io
ABOUT CARLOS “LOS” ARIAS, J.D.
CO-FOUNDER, CHIEF EXECUTIVE OFFICER OF GREEN HORIZONS
Arias is regarded industry wide as a plant medicine expert, honed from his Cuban/Brazilian lineage and years of dedication to studying and working with medicinal plants all over the world. A lawyer by training, Arias is responsible for the Company’s key strategic partnerships.
ABOUT MICHAEL C. MEADE
CHIEF EXECUTIVE OFFICER OF COACHELLA CANN PARK, CO-FOUNDER AND PRESIDENT OF GREEN HORIZONS
In addition to securing the first issued cannabis licenses in Riverside County 15 years ago for cultivation and retail, Meade went on to build a cannabis real estate empire in the desert valley, fueled by Wilson Meade commercial brokerage and Desert Rock Development.
ABOUT STAR BRANDING INVESTMENT GROUP
Star Branding Investment Group, LLC is a private investment vehicle founded by Mr. Tommy Hilfiger and Mr. Joe Lamastra, through which it, and its subsidiaries seek investments in businesses across a broad range of industries.
For media inquiries please contact: firstname.lastname@example.org
A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/02b2422e-e386-488a-b236-26245b458b36To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Ted Elvhage, Board member in Fingerprint Cards AB (publ), has sold shares due to private financial commitments19.5.2022 14:14:57 CEST | Press release
Ted Elvhage, Board member in Fingerprint Cards AB, has sold 975,000 shares in Fingerprints. “The reason for my sale of shares is private financial commitments. I have an unchanged strong belief in the company's future and plan to invest in Fingerprints again as soon as it is possible for me to do so,” comments Ted Elvhage. Link to PDMR transactions register. For further information, please contact: Investor Relations: +46(0)10-172 00 10, email@example.com Press: +46(0)10-172 00 20, firstname.lastname@example.org About Fingerprints Fingerprint Cards AB (Fingerprints) – the world’s leading biometrics company, with its roots in Sweden. We believe in a secure and seamless universe, where you are the key to everything. Our solutions are found in hundreds of millions of devices and applications, and are used billions of times every day, providing safe and convenient identification and authentication with a human touch. For more information visit our website, read our blog, and follow us on
GOGL – Q1 2022 Presentation19.5.2022 13:59:16 CEST | Press release
Please find enclosed the presentation of Golden Ocean Group Limited’s first quarter 2022 results for today’s webcast / conference call at 15:00 CET. Attend by Webcast: Use to the follow link prior to the webcast: https://edge.media-server.com/mmc/p/zgb9bp5w Attend by Conference Call: Applicable dial-in telephone numbers are as follows: International Dial-In: +44 (0) 2071 92 8338 United Kingdom Toll Free: 08002796619 Norway Toll Free: 800 56 865 US Toll-Free: +1 877 870 9135 The presentation material which will be used in the teleconference/webcast can be downloaded on www.goldenocean.bm and replay details will also be available at this website. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment Golden Ocean Q1 2022 - Presentation
Vow ASA: Minutes of Annual General Meeting19.5.2022 12:40:04 CEST | Press release
The annual general meeting of Vow ASA was held today on 19 May 2022 at the company's premises at Lysaker Torg 12, 1366 Lysaker, Norway. All matters on the agenda were approved, cf. the notice of the Annual General Meeting that was published on 28 April 2022. The complete minutes are attached to this release. For further information, please contact: Erik Magelssen, CFO, Vow ASA Tel: +47 928 88 728 Email: email@example.com About Vow Vow and its subsidiaries Scanship, C.H. Evensen and Etia are passionate about preventing pollution. The company’s world leading solutions convert biomass and waste into valuable resources and generate clean energy for a wide range of industries. Cruise ships on every ocean have Vow technology inside which processes waste and purifies wastewater. Fish farmers are adopting similar solutions, and public utilities and industries use our solutions for sludge processing, waste management and biogas production on land. With advanced technologies and solution
Bavarian Nordic modtager vaccineordre fra europæisk land efter bekræftede tilfælde af abekopper19.5.2022 11:46:42 CEST | pressemeddelelse
KØBENHAVN, Danmark, 19. maj 2022 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at selskabet har indgået en kontrakt med et unavngivet europæisk land vedrørende levering af koppevaccinen IMVANEX® i forbindelse med nye tilfælde af abekopper, der er identificeret i løbet af maj 2022. Det første europæiske tilfælde blev bekræftet den 7. maj 2022 hos en person, der vendte hjem fra en rejse til Nigeria, hvor abekopper er naturligt forekommende. Efterfølgende er der bekræftet mere end 20 tilfælde i England, Portugal og Spanien, og flere formodede tilfælde er ved at blive undersøgt. De fleste infektioner lader til at være sket lokalt i de tre lande. I USA er der bekræftet et enkelt tilfælde hos en rejsende fra Canada, hvor der endnu ikke foreligger bekræftede tilfælde, men adskillige formodede tilfælde er ved at blive undersøgt. Bavarian Nordics koppevaccine er godkendt i USA under navnet JYNNEOS® og i Canada under navnet IMVAMUNE®. I begge lande er godkendelsen udvidet til at omfatte abek
Bavarian Nordic Secures Vaccine Order from European Country After Confirmed Monkeypox Cases19.5.2022 11:46:42 CEST | Press release
COPENHAGEN, Denmark, May 19, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company has secured a contract with an undisclosed European country to supply its IMVANEX® smallpox vaccine in response to new cases of monkeypox evolving during May 2022. The first European case was confirmed on May 7, 2022, in an individual who returned from a travel to Nigeria, where monkeypox is endemic. Subsequently, more than 20 cases have been confirmed across England, Portugal and Spain with additional suspected cases currently being investigated. Evidence points to that most of the infections have been acquired locally in these countries. In the US, a single case has been confirmed in a traveler from Canada, where no cases are yet confirmed, but several remain under investigation. Bavarian Nordic’s smallpox vaccine is approved in the U.S. as JYNNEOS® and in Canada as IMVAMUNE®, both places with the approval extended to cover the monkeypox indication. The vaccine is approved in Europe a